R&D process
We conduct R&D on entire process of new drug development, namely, “Active Pharmaceutical Ingredients, Finished pharmaceutical products, platform(DDS)”. We are also pursuing the challenge of developing innovative new drugs through the fusion of bio and chemical substances.
Chemical
Active Pharmaceutical Ingredients
Development of high value-added drug substances such as antibiotics (MRSA) and antiviral drugs
Synthetic new drugs
Research on maximization of drug efficacy through development of new drug substances based on organic synthesis technology and drug combinations
Contrast agents
Development of a new x-ray contrast agents
Bio
Gene therapy drugs
Development of pDNA/mRNA/AAV, Lenti-based therapeutics for the treatment of rare, chronic, and intractable diseases
Cell therapy
Development of customized therapeutics for treatment of rare and intractable diseases Development of NK cell therapy targeted for solid tumors
-
Gene Theraphy Platform / DDS
Development of a safe and effective platform including viral vector for delivering gene therapy
Drug Delivery System
(ElectroPorator, Formulation, etc) 
Antibody therapy
Development of therapeutic agents with minimal side effects by acting specifically on the target
Natural Products
Natural medicine/health functional food
Natural new drug development and mass production research, and health functional food research
All rights Reserved.